"The high raw material prices create a two-sided situation whereby some economies are helped by the high prices, while some sectors suffer due to heightened costs."
"Nivagen has excellent connections and market access, and we are always looking to in-license FDA-approved products that leverage our expertise in launching in the US market."
"With nearly 40% of all new FDA approvals over the last two years coming from companies with a footprint in NJ, our state continues to lead the way in bringing new therapies and cures to patients."
"ESG is ethically and financially necessary for companies in the current environment, so we wanted to help them navigate the complexities of reporting."
"One of our major value propositions entails “disruption by elimination” by developing mine hardened multi-variable measurement and devices that eliminate complex PLCs, cabinets, engineering services and wiring."
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.